Table 2.
Study | N | Target | Stimulation Settings | Responder Criteria | Remission Criteria | At End of Trial Responders | Remitters | Primary Study Endpoint Met? | |
---|---|---|---|---|---|---|---|---|
Internal Capsule (VC/VS) | ||||||||
(Abelson et al., 2005) | 4 | Internal Capsule | 130 Hz–150 Hz | ≥ 35% decrease in Y-BOCS | Not assessed | 25% (1) | N/A | No |
(Goodman et al., 2010) | 6 | VC/VS | 130 Hz–135 Hz | ≥ 35% decrease in Y-BOCS AND final Y-BOCS score ≤ 16 | Not assessed | 67% (4) | N/A | Yes |
(Luyten, Hendrickx, Raymaekers, Gabriels, & Nuttin, 2016) | 24 | Internal Capsule | 85 Hz–130 Hz | ≥ 35% decrease in Y-BOCS | Not assessed | 67% (16) | N/A | Yes |
(Barcia et al., 2019) | 7 | Internal Capsule | 130 Hz | ≥ 35% decrease in Y-BOCS | Not assessed | 85% (6) | N/A | No |
Subthalamic Nucleus (STN) | ||||||||
(Mallet et al., 2008) | 8 | Subthalamic Nucleus | 130 Hz | ≥ 25% decrease in Y-BOCS | Not assessed | 75% (6) | N/A | Yes |
Combined VC/VS and STN | ||||||||
(Tyagi et al., 2019) | 6 | VC/VS (Internal Capsule) and STN | 130 Hz | ≥ 35% decrease in Y-BOCS | Not assessed | 100% (6) | N/A | Yes |